Donisi Health

Donisi Health is a medical technology company providing user-friendly in-home health detection solutions for patients with congestive heart failure (CHF) and other chronic diseases. Donisi enables a user-friendly preemptive approach to cardiac and pulmonary health monitoring in the home, helping to optimize the continuum of care for patients with CHF and other chronic diseases and avoid unnecessary rehospitalization. Based on Donisi's FDA-cleared technology and backed by 11 granted patents, Donisi's contact-free health detection works free from wires, wearables, and patches. The company's patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators. Donisi's clinically validated contact-free technology can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.

Donisi Health has raised $27.2M in total funding across 6 rounds. The company is currently at the B stage. Key investors include The Chartered Group, OTV, Johnson Controls.

Donisi Health was founded in 2015 by Zeev Zalevsky (Co-founder & CTO).

Donisi Health operates in Health Tech & Life Sciences, Medical Devices, Medical Monitors, Digital Healthcare, Patient Remote Monitoring, with core technologies in Platforms & Interfaces, Mobile, Sensing, Acoustics, Vibration, Biometrics, Artificial Intelligence, Deep Learning, Machine Learning. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Healthcare, Patients, Providers, Consumers, Demographics & Family, Seniors.

Donisi Health is based in HaNechoshet Street 6, Tel Aviv, Israel, Center District. The company also has offices abroad.